Bank of New York Mellon Corp Sells 26,070 Shares of Xylem Inc. $XYL

Bank of New York Mellon Corp lowered its holdings in shares of Xylem Inc. (NYSE:XYLFree Report) by 2.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,182,460 shares of the industrial products company’s stock after selling 26,070 shares during the quarter. Bank of New York Mellon Corp’s holdings in Xylem were worth $141,304,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. J. Stern & Co. LLP grew its holdings in Xylem by 12,326.6% during the 4th quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock valued at $6,189,132,000 after buying an additional 45,082,435 shares in the last quarter. Norges Bank bought a new position in shares of Xylem during the fourth quarter worth $361,012,000. Balyasny Asset Management L.P. grew its stake in Xylem by 346.2% during the third quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company’s stock valued at $105,160,000 after acquiring an additional 553,152 shares in the last quarter. Adage Capital Partners GP L.L.C. bought a new stake in Xylem in the 2nd quarter valued at $64,407,000. Finally, SG Americas Securities LLC increased its holdings in Xylem by 255.4% in the 1st quarter. SG Americas Securities LLC now owns 681,904 shares of the industrial products company’s stock valued at $81,488,000 after acquiring an additional 490,040 shares during the last quarter. Institutional investors own 87.96% of the company’s stock.

Xylem Price Performance

XYL stock opened at $122.96 on Monday. Xylem Inc. has a 52 week low of $105.29 and a 52 week high of $154.27. The firm has a market capitalization of $29.23 billion, a P/E ratio of 30.59, a price-to-earnings-growth ratio of 1.75 and a beta of 1.03. The company has a fifty day simple moving average of $113.23 and a two-hundred day simple moving average of $123.37. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13.

Xylem (NYSE:XYLGet Free Report) last posted its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. The firm had revenue of $2.12 billion for the quarter, compared to the consensus estimate of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The business’s quarterly revenue was up 2.7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Analysts anticipate that Xylem Inc. will post 5.51 earnings per share for the current fiscal year.

Xylem Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th were paid a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend was Thursday, May 28th. Xylem’s payout ratio is presently 42.79%.

Analyst Ratings Changes

XYL has been the subject of several research reports. Oppenheimer dropped their price objective on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a report on Wednesday, April 29th. Royal Bank Of Canada lifted their target price on Xylem from $157.00 to $159.00 and gave the stock an “outperform” rating in a report on Thursday. Stifel Nicolaus decreased their target price on Xylem from $163.00 to $159.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. CLSA raised Xylem to a “hold” rating in a research note on Thursday, June 25th. Finally, UBS Group raised their price target on Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Eight investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $153.31.

Check Out Our Latest Stock Report on Xylem

Insider Buying and Selling

In related news, Director Jerome A. Peribere bought 1,210 shares of the company’s stock in a transaction dated Monday, May 4th. The stock was purchased at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the acquisition, the director owned 27,209 shares in the company, valued at $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the transaction, the chief accounting officer directly owned 3,605 shares in the company, valued at approximately $423,443.30. This represents a 54.22% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.32% of the company’s stock.

Xylem Company Profile

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

See Also

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.